U.S. Markets closed

Shire plc (SHP.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
4,626.00+166.00 (+3.72%)
At close: 4:38PM BST
People also watch
SN.LWPP.LAZN.LSMIN.LSDR.L
Full screen
Previous Close4,460.00
Open4,552.00
Bid4,460.00 x 51000
Ask4,649.00 x 53800
Day's Range4,517.00 - 4,640.50
52 Week Range2,707.19 - 5,377.00
Volume2,604,543
Avg. Volume2,382,507
Market Cap41.63B
Beta1.80
PE Ratio (TTM)142.34
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.26 (0.48%)
Ex-Dividend Date2016-09-08
1y Target EstN/A
  • Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
    Zacks13 hours ago

    Shire (SHPG) Receives MAA Validation for Veyvondi by EMA

    Shire plc (SHPG) announced that the European Medicines Agency (EMA) validated the Marketing Authorization Application (MAA) for Veyvondi to prevent and treat bleeding episodes and peri-operative bleeding in adults diagnosed with von Willebrand Disease.

  • TheStreet.com14 hours ago

    Biotech Movers: Shire, Bellicum, Organovo

    Shire, Bellicum Pharmaceuticals and Organovo Holdings were among the biotech stock movers in premarket trading on June 22.

  • Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US
    Zacks2 days ago

    Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US

    Shire Plc (SHPG) announced that the FDA has approved its new attention deficit hyperactivity disorder (ADHD) drug, Mydayis (mixed salts of a single-entity amphetamine product) in patients 13 years and older